HOME >> BIOLOGY >> NEWS
Food safety: French discovery explains how Listeria penetrates the body, and may suggest new drug delivery strategies

e to enter the bloodstream, where it disseminates to the central nervous system and the placenta. But, the molecular events that allow Listeria to cross the intestinal barrier have remained a mystery--until now.

In previous studies, Cossart and her colleagues--including Jean Louis Gaillard, Jerme Mengaud and Marc Lecuit--had shown that a protein on Listeria's surface called "internalin" interacts with a receptor, E-cadherin found on cultured cells derived from the intestine. Similar to a key-and-lock system, internalin interacts with E-cadherin to promote the entry of Listeria into intestinal cells. Listeria can then cross the intestine and pass into the bloodstream, scientists said.

Studying this mechanism in animals proved difficult, however, because rats and mice produce a form of cadherin that doesn't bind with internalin. Fortunately, guinea pigs generate a suitable version of the protein, making these animals a useful model for studying oral Listeria infection. The difference between the two forms of cadherin, Cossart explained, is a single amino acid in the 16th position of cadherin's molecular chain.

For their latest Science study, Lecuit et al.(Cossart's team in collaboration with transgenesis expert Charles Babinet and other scientists at the Pasteur Institute), investigated oral infection mechanisms within guinea pigs and transgenic mice, which had been genetically modified to express the human version of cadherin in the intestine. Animals received oral doses of both wild-type Listeria, as well as a mutant, internalin-free version of the bacterium. Wild Listeria, featuring the internalin protein, proved fatal in most cases, whereas the mutant strain caused no deaths and failed to cross the intestine and invade organ tissues.

Thus, the French investigation identifies a "virulence factor" or molecular mechanism by which Listeria causes disease, thereby addressing a key recommenda
'"/>

Contact: Ginger Pinholster
gpinhols@aaas.org
202-326-6421
American Association for the Advancement of Science
31-May-2001


Page: 1 2 3 4

Related biology news :

1. Bones from French cave show Neanderthals, Cro-Magnon hunted same prey
2. Fire on French Riviera
3. Smaller food portions may explain the French paradox of rich foods and a svelte population
4. ESA providing Kyoto estimates of French Guianas tropical forests
5. Researchers develop white wine with cholesterol-lowering benefits, discover Israeli wines healthier than French wines
6. Beyond the French paradox
7. Study seems to show why French suffer less heart disease, cancer
8. The Reason The French Have Low Levels Of Heart Disease
9. New Technology Turns French Fry Oil Into Diesel Fuel
10. French Researchers Breed Flightless Ladybirds As Pest-Killers
11. Very Fruitful Collaboration Between French And German Scientists Yields Unusual Insights Into The Structure Of Membrane Proteins

Post Your Comments:
(Date:1/22/2015)... Technology Showcase, Hall E -   EyeLock Inc. , a ... will showcase its EyeLock ID technology integrated in a 3D ... Oak Ridge National Laboratory (ORNL) at the 2015 ... authentication technology is being used to validate the driver and ...
(Date:1/22/2015)... , Jan. 16, 2015  A man-made form of ... and other mental capabilities in adults with mild cognitive ... study led by researchers at Wake Forest Baptist Medical ... diagnosed with amnesic mild cognitive impairment (MCI) or mild ...
(Date:1/22/2015)... YORK and POINT ROBERTS, Washington ... news source covering leading sectors including technology and tech stocks, ... Privacy marketplace featuring master pickpocket and security consultant Apollo ... is stolen and talks about the Wocket™ biometric smart wallet, ...
Breaking Biology News(10 mins):EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 3
(Date:2/27/2015)... , Feb. 27, 2015 A ... the NCATS rare-diseases portfolio " in Science ... new financing technique to reduce the risk associated ... and potentially unlock new levels of funding for ... product of a unique collaboration between scientists at ...
(Date:2/27/2015)... 27, 2015  Pfenex Inc. (NYSE MKT: PFNX), a ... therapeutics, today announced that it will be presenting at ... March 2 nd at 3pm PST. Patrick Lucy, chief ... discussing the current state of the biosimilar industry landscape ... For more information on CALBIO 2015 and ...
(Date:2/26/2015)... -- S&P Capital IQ (MHFI) announced today that it ... Therapeutics Holdings Inc . MabVax Therapeutics ... focused on the development of vaccine and antibody-based therapies ... cancer. MabVax has discovered a pipeline of human monoclonal ... by patients who have been immunized against targeted cancers. ...
(Date:2/26/2015)... 2015   Regulus Therapeutics Inc . (NASDAQ: ... and development of innovative medicines targeting microRNAs, today announced ... Chief Executive Officer of Regulus, will present a company ... Annual Healthcare Conference on Wednesday, March 4, 2015 at ... the Boston Marriott Copley Place.  The ...
Breaking Biology Technology:New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 2Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 3
Cached News: